Sequencing of all 10 RHD exons from genomic DNA showed that at least 16 different molecular weak D types exist. Fourteen of the weak D types were caused by a single missense point mutation located within the transmembraneous or intracellular regions of the protein. Two weak D types (types 4 and 14) are each associated with nucleotide substitutions at three nonadjacent positions. In a population-based investigation of 161 weak D samples from Southwestern Germany, 1 all samples showed an aberrant D sequence. Weak D types 1 to 5 were detected in more than a single sample and thus occurred with a haplotype frequency greater than 1 in 25,000.
These findings prompted us to compare the molecular basis of the weak D samples from Southwestern Germany to weak D blood specimens from 436 persons from the Tyrol region of Austria or from Northern Germany. For this task and for routine RHD typing, we developed and validated a new modular system of six PCRs with sequencespecific primers (PCR-SSP) performed under identical thermocycling conditions to detect the mutations specific for weak D types 1 to 5 and the partial D phenotype HMi with a weak D expression. We also mixed all six reactions into a single tube and then performed an automated fragment length analysis. With these strategies, we observed significant differences in the regional distribution of the three most common weak D types. Only a few samples did not provide a positive reaction in the weak D PCR-SSP panel. Sequencing RHD exons 1 to 10 of such samples found three new alleles, including one new molecular weak D type.
MATERIALS AND METHODS

Blood samples
EDTA or citrate blood samples were collected from White blood donors in the Tyrol or in Northern Germany. The samples from donors marked as weak D in their files were investigated. If weak D PCR-SSP typing was negative, the serologic weak D assay was repeated by the following method.
Agglutination was tested in both a gel matrix test ([LISS = indirect antiglobulin test [IAT]] 37°C; DiaMed-ID Micro
Typing System, DiaMed, Cressier sur Morat, Switzerland) using a monoclonal antiserum (DiaClon Anti-D, IgG + IgM, DiaMed) according to the manufacturer's instructions and in tube tests, performed with a washed RBC suspension using two approved, agglutinating, D typing reagents (Seraclone Anti-D [226], IgM, Biotest AG, Dreieich, Germany; and Gamma-clone Anti-D, monoclonal blend, Gamma Biologicals, Houston, TX). Samples with weak reactions in both the gel matrix and tube test were submitted to further analysis by nucleotide sequencing.
Genomic DNA was prepared as described previously. 2 RBCs for flow cytometry were glycerolized for storage at -70°C 3 and kept frozen until final analysis.
PCR-SSP for weak D types 1 to 5 and partial D phenotype HMi
DNA from all weak D samples was investigated by PCR-SSP RHD exon scanning as described.
2 PCR primers for detection of weak D types and the partial D phenotype HMi were selected with the help of software (MacVector, version 4.5.3, Kodak, New Haven, CT). Oligonucleotides were synthesized and supplied by Microsynth (Balgach, Switzerland).
The concentration of the detection primers (Table 1 ) was 250 nM, with the exception of 700 nM for the primers for weak D type 2 and 350 nM for HMi. Control primers detecting a fragment from the human growth hormone (HGH) gene (position 5559-5992 4 ) were added to each PCR in a final concentration of 60 nM. All amplification reactions were performed under previously published conditions. 2
Single-tube method for all six PCR-SSP
Fluorescence-labeled primers (Table 1; Applied Biosystems, Weiterstadt, Germany) for PCR-SSP for all 5 weak D types and HMi were incorporated into a single tube. The primer pair (4,7,2´,7´-tetrachloro-6-carboxyfluorescein labeling of the sense primer) for exon 2 of the RHD/C genes 2 was added as internal control instead of the HGH primers with their large product size. Amplification of approximately 50 ng of DNA in a total volume of 20 µL was performed as described above. After PCR, free primers were removed by using a PCR purification kit (QIAquick, Qiagen, Hilden, Germany). Formamide (10 µL) and size standards (1 µL; Genescan 350, Applied Biosystems) were added to the purified amplicons (5 µL) for automated processing with a genetic analyzer (ABI Prism 310, Applied Biosystems). Each sample was loaded by application of 2 kV for 30 seconds. The amplicons were separated by electrophoresis (15 kV, 20 min) in a 50-cm capillary filled with polymer (POP-6, Applied Biosystems). The data from each run were collected and evaluated batchwise with software (Genotyper, Applied Biosystems) to automatically identify each amplicon by both its size and its fluorescence.
Sequencing of the 10 RHD exons from genomic DNA
Nucleotide sequencing was performed as described previously.
1,5
Flow cytometric measurement of D density
Epitope densities were determined with two MoAbs, H41 and BS221 (Biotest AG), by indirect immunofluorescence using a standard cell of known antigen density as described previously.
5,6
Serologic characterization
Agglutination was tested in a gel matrix test (LISS-IAT 37°C, DiaMed-ID Micro Typing System) as reported. 5
Statistical analysis
Frequencies were compared by using the χ 2 test for 3-×-4 or 2-×-4 contingency tables. The Bonferroni-Holm adjustment was applied to correct for multiple testing. Analyses were performed with software (SPSS 5.1 for Macintosh, SPSS, Chicago, IL).
RESULTS
PCR-SSP systems for weak D types 1 to 5 and partial D phenotype HMi
SSP systems for the weak D and HMi panel were designed (Table 1) to generate specific amplicons at identical thermocycling conditions. Results of this modular PCR system are presented in Fig. 1 .
As an alternative screening method, fluorescence-labeled primers were added (Table 1) to combine all six PCR-SSP in one reaction tube. After capillary electrophoresis, the reaction products were identified by both their size and the type of fluorescence. The instrument for fragment length analysis (ABI Prism 310 genetic analyzer) automatically processes up to 96 samples in a single run. The method reliably detected samples from persons with weak D types 1 to 5 and HMi. It did not generate any false-positive signal in a series of DNA samples from 100 consecutive donors with a normal D+ phenotype.
Weak D collection and evaluation
Blood samples from 436 persons with a history of a weak D phenotype were collected in the Tyrol and Northern Germany. All samples were tested with PCR-SSP for exon D screening as described previously Table 1 . not be confirmed: their Rh phenotypes were CcDee in 13 cases and CCDee in 7 cases. Of these samples, the single CcDee sample from one collection site with a history of weak D not confirmed by the reevaluation was investigated by sequencing; it also revealed an abnormal RHD allele.
After the selection, 416 samples were finally included in the molecular investigation of weak D samples from the Tyrol and Northern Germany ( 
Molecular structure and phenotype of the new RHD alleles identified
Sequencing of the weak D phenotype samples without a positive weak D PCR-SSP identified two rare weak D types described previously (types 13 and 14) and three new RHD alleles (Table 3) .
Weak D type 21 had a missense mutation in its intracellular segment. On serologic testing, it possessed all D epitopes evaluated (Table 4) and had an antigen density of about 5200 per cell. Despite its weak D-like molecular structure and reduced antigen density, it may be typed as normal D by current serologic criteria.
A second allele, dubbed D HO (Table 3) , had a single missense mutation located in the fourth extracellular loop), similar to that of D HR. It was not agglutinated by antibodies directed to epitopes epD4, epD11, and epD31; however, its antigen density of 1300 per cell was rather low, and it is not clear whether the negative reactions are due to qualitative or quantitative changes in D expression.
A third allele, dubbed D category V type VII, had previously been observed by us in three samples from Switzerland and in a sample from Southwestern Germany (unpublished data). It represented an RHD-CE(5)-D hybrid allele (Table 3 ) with a subtotal substitution of RHD exon 5 by RHCE exon 5. Its serologic profile was similar to that of D category Va (Table 4) without the differentiation between type I and II. However, it had a much lower antigen density (estimate based on the two DMoAbs: 1180-1280 antigens/ cell), and it failed to react with several examples of anti-D probably due to the low antigen density.
Distribution of weak D types in three Central European regions
The results of the genomic RHD typing are compared to those in a previous population-based molecular analysis in Southwestern Germany.
1 In all three regions with Germanspeaking populations, persons with a weak D DNA type 1, 2, or 3 consistently contributed more than 90 percent of all molecular weak D types ( served for type 3. We measured the antigen densities of type 3 RBCs from the three regions by flow cytometry. A similar distribution of the values for the individual samples was observed in all three regions (Fig. 2) . The median value of 1505 epitopes per cell in the Tyrol did not differ from the medians of 1732 for Northern Germany and 1768 for Southwestern Germany. The occurrence of weak D types other than 1, 2, or 3 is shown in Table 6 . Statistical analysis of the frequencies of the rare weak D types was not planned because of the low numbers expected. However, retrospective comparison of the data revealed a north-south gradient of the weak D types underlying ccD.Ee samples. In Northern Germany, all 44 such samples were weak D type 2. In Southwestern Germany, the vast majority (43) were type 2, and yet two type 5 and several rarer alleles were also observed.
DISCUSSION
A method for PCR-SSP detection of the five most common molecular weak D types 1 was established. This set and the partial D HMi PCR extend the modular system of seven reactions for RHD exon screening and of six reactions for C, C w , c, E, and e DNA typing by PCR-SSP. 2,8,9 All these reactions are designed to reliably operate under identical thermocycling conditions. This strategy simplifies the set-up for DNA typing of diverse alleles and of larger numbers of samples.
Depending on the specific resources available to a laboratory, the typing of hundreds of DNA samples and thus the need for analyzing thousands of separate reactions are laborious challenges. Therefore, we also combined the six primer pairs plus a control reaction into a single reaction tube. Combination methods with three or more primer pairs have also been developed for blood group typing. 10, 11 These methods enhance the accuracy and the speed of typing and minimize the DNA amount. Their successful applications underscore the fact that many different PCRs can reliably be combined in a single tube.
We coupled the combined PCR system to automated capillary electrophoresis and fluorescence detection of the amplicons. This semi-automated method efficiently analyzed large sample numbers. Capillary electrophoresis reliably separates amplicons differing in size by only a single base pair, and the inclusion of internal size standards into each separation ensures a very high reproducibility of the absolute size measurement of the PCR products. Generating amplicons with different fluorescence labels further reduces a potential risk of misidentifying PCR products of similar size, and both the single-tube reaction and the automated processing should help to minimize potential sample mix-ups. A disadvantage of this approach is the need for the special instrumentation that also serves nucleotide sequencing. The PCR-SSP for molecular weak D typing may offer a valuable tool for the evaluation of weak D phenotypes independently of its application as a semi-automated combined or a conventional method. We evaluated the new method for PCR-SSP weak D typing by our screening of samples with a history of a weak D phenotype from the Tyrol and Northern Germany. The study was not designed as a prospective investigation applying prespecified criteria for the phenotypic selection of samples. The cutoff between "normal" and "weak" D is not internationally standardized and may have varied between laboratories and time periods. Therefore, the results may be affected by selection bias. Despite these limitations, DNA typing of these samples provided several important new insights.
The molecular weak D types 1, 2, and 3 contributed more than 90 percent of all molecular weak D samples in both Austria and Northern Germany (Table 5) . Among the less frequent molecular weak D types, only types 4 and 5 were identified in more than one sample (Table 6 ). All other weak D types were so rare that their frequency cannot be reliably estimated from the available data. This finding corroborates the results from the previous study 1 that the molecular weak D types 1 to 3 represent the vast majority of samples of all 21 types reported so far.
Beyond this general pattern in the molecular causes of weak D, a more detailed analysis revealed substantial differences between the populations (Table 5) : In Northern Germany, type 1 was most frequent, with 60 percent and more. In the Tyrol, type 3 represented about half of all samples. Type 2 and 3 were observed with similar frequencies in Northern Germany. In Southwestern Germany, type 3 samples represented less than 20 percent of the type 2 samples. Because weak D type 3 has a rather high antigen density, different cutoff values of the weak D serotyping could explain these differences. However, we observed no obvious difference in the antigen densities of weak D type 3 samples collected at different sites (Fig. 2) . This finding suggests that samples identified by molecular typing may be of value for the standardization of serologic methods.
The relative frequency of weak D type 2 among samples with weak D expression diminished from north to south. Both type 2 and type 5 have a very low antigen density and certainly would be considered weak D in any laboratory, so that this comparison cannot be due to a selection bias. The diminishing role of weak D type 2 in the Tyrol becomes even more impressive if D category VI with its low D antigen density is also considered. We observed no D category VI type I sample in Northern Germany, but 15 such samples in the Tyrol. Hence, weak D type 2 makes up 100 percent of all ccD.Ee samples with low D antigen in Northern Germany, but only 35 percent of those in the Tyrol.
All samples with a weak D phenotype according to the current standard that were not D category VI or VII represented either previously reported rare weak D types (1 sample each of types 13 and 14 in the Tyrol) or new alleles (Table 3) .
Weak D type 21 harboring a substitution in its intracellular segment fits the structural scheme previously ob- [13] [14] [15] [16] in that it possesses the E233Q substitution. The only difference in D category V types II and VII is the maintenance of the ultimate, D-typic lysine in exon 5 at codon 267, and the only difference from D category V type VI is the arginine at codon 263. However, D category V type VII has a considerably reduced antigen density that is probably unique among D category V, which results in negative reactions with many antibodies directed at epitopes present in D category V. This observation underscores the possibility that minor molecular differences may lead to considerable phenotypic variation. It is interesting that, before this study, we observed this type in several samples from Switzerland that were investigated because of the combination of a low antigen density and absent reactivity with many D MoAbs. These observations probably indicate a local accumulation of this otherwise rare RHD allele in Switzerland.
If we exclude those samples that do not fit the current weak D serotyping criteria, our results support the original observation of missense mutations in all 161 weak D samples collected in Southern Germany for a total of 577 weak D samples collected from a larger region of Central Europe. It also corroborates the finding that the molecular weak D types 1 to 3 represent the vast majority of all weak D samples. The only other genotype occurring with considerable frequency among samples with a weak D expression in whites is D category VI. 17 Because this genotype is also detected by our combination of exon-specific PCR-SSP and weak D PCR, we are able to identify the underlying genotype for more than 90 percent of all samples with weak D expression. During the course of our study, the presence of an RHD pseudogene (RH-) was reported in a substantial portion of D-Africans. 18 RH-is not expected to affect the detection of the common weak D alleles by our PCR system. Our combination of serotyping and DNA analysis for the investigation of weak D samples is essential to a reliable assessment of samples with an African background. A pure DNA typing strategy, however, should include the detection of the RH-gene 18 or the RHD deletion. 19 Our observations found substantial differences in the regional distribution of genotypes underlying samples classified as weak D by the regional laboratory. The PCR method of rapidly identifying the common weak D types will ensure that, in the future, different laboratories will be able to share observations on defined molecular entities rather than a "weak D" phenotype defined by serologic testing, which may represent quite different entities.
The predominance of weak D types 1, 2, and 3 is an important finding consistently observed for all involved regions and laboratories. No alloanti-D has been found in persons with these most common weak D types. 5 Therefore, our results qualify the PCR-SSP detection of these three types as a simple and valuable tool for identifying the molecular basis of the majority of weak D phenotypes. The transfusion of D RBCs or becoming pregnant may be associated with a minimal risk of alloimmunization for these persons. 5
